← Leaderboards
Si-Yi Chen
Baylor College Of Medicine
$10,785,586
Attributed
$10,785,586
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$10,785,586 · 8
By mechanism
R01$9,878,086 · 6
R21$907,500 · 2
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- De-Quan Li$2,514,559
- Margaret E. Conner$4,972,628
- Frank M Orson$3,097,411
- Xue F Huang$1,537,593
- Xinfang Yu$956,531
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsAntigen PresentationSignal TransductionImmuneInhibitor/AntagonistImmune ResponseResponseImmunizationCytokineMemoryAntigensAntigen-Presenting CellsVaccinationHiv InfectionsPlayCytokine Inducible Sh2-Containing ProteinImmunityMaintenanceT-LymphocyteInfectionLaboratory MouseProgramsIn VivoAdjuvant
Grant awards (37)
Novel anti-CD19 CAR-T cells for lupus nephritis treatment$206,250
R21 · FY2022 · AI · contact PI
Novel anti-CD19 CAR-T cells for lupus nephritis treatment$247,500
R21 · FY2021 · AI · contact PI
New adjuvants to induce neutralizing HIV antibody responses$206,250
R21 · FY2016 · AI · contact PI
New adjuvants to induce neutralizing HIV antibody responses$247,500
R21 · FY2015 · AI · contact PI
Developing novel adjuvants for HIV vaccination$410,435
R01 · FY2013 · AI · contact PI
Overcoming Immune Suppression to Enhance Tumor Vaccine Efficacy$297,506
R01 · FY2013 · CA · contact PI
Developing novel adjuvants for HIV vaccination$436,634
R01 · FY2012 · AI · contact PI
Overcoming Immune Suppression to Enhance Tumor Vaccine Efficacy$316,496
R01 · FY2012 · CA · contact PI
Developing novel adjuvants for HIV vaccination$436,634
R01 · FY2011 · AI · contact PI
Overcoming Immune Suppression to Enhance Tumor Vaccine Efficacy$316,496
R01 · FY2011 · CA · contact PI
Developing novel adjuvants for HIV vaccination$441,045
R01 · FY2010 · AI · contact PI
HIV vaccination via inhibition of cytokine signaling inhibitors$345,855
R01 · FY2010 · AI · contact PI
Overcoming Immune Suppression to Enhance Tumor Vaccine Efficacy$326,284
R01 · FY2010 · CA · contact PI
Developing novel adjuvants for HIV vaccination$447,791
R01 · FY2009 · AI · contact PI
HIV vaccination via inhibition of cytokine signaling inhibitors$349,348
R01 · FY2009 · AI · contact PI
Overcoming Immune Suppression to Enhance Tumor Vaccine Efficacy$328,038
R01 · FY2009 · CA · contact PI
Tumor Vaccination: Modulation of Inhibitory Signaling in Antigen-presenting cells$252,841
R01 · FY2009 · CA · contact PI
HIV vaccination via inhibition of cytokine signaling inhibitors$349,348
R01 · FY2008 · AI · contact PI
Tumor Vaccination: Modulation of Inhibitory Signaling in Antigen-presenting cells$252,841
R01 · FY2008 · CA · contact PI
HIV vaccination via inhibition of cytokine signaling inhibitors$178,662
R01 · FY2007 · AI · contact PI
HIV vaccination via inhibition of cytokine signaling inhibitors$161,968
R01 · FY2007 · AI · contact PI
Tumor Vaccination: Modulation of Inhibitory Signaling in Antigen-presenting cells$130,281
R01 · FY2007 · CA · contact PI
Tumor Vaccination: Modulation of Inhibitory Signaling in Antigen-presenting cells$112,785
R01 · FY2007 · CA · contact PI
HIV vaccination via inhibition of cytokine signaling inhibitors$337,500
R01 · FY2006 · AI · contact PI
Antigen Specific T-Helper to Enhance Antitumor Immunity$294,294
R01 · FY2006 · CA · contact PI
Tumor vaccination by modulation of inhibitory signaling in antigen-presenting cel$239,625
R01 · FY2006 · CA · contact PI
Antigen Specific T-Helper to Enhance Antitumor Immunity$301,376
R01 · FY2005 · CA
Antigen Specific T-Helper to Enhance Antitumor Immunity$301,376
R01 · FY2004 · CA
INACTIVATION OF CHEMOKINE RECEPTORS BY INTRAKINES$300,000
R01 · FY2004 · AI
Antigen Specific T-Helper to Enhance Antitumor Immunity$301,376
R01 · FY2003 · CA
INACTIVATION OF CHEMOKINE RECEPTORS BY INTRAKINES$300,000
R01 · FY2003 · AI
A UNIFYING ANTIGEN PRESENTATION STRATEGY$261,625
R01 · FY2003 · AI
Antigen Specific T-Helper to Enhance Antitumor Immunity$301,376
R01 · FY2002 · CA
INACTIVATION OF CHEMOKINE RECEPTORS BY INTRAKINES$262,500
R01 · FY2002 · AI
A UNIFYING ANTIGEN PRESENTATION STRATEGY$261,625
R01 · FY2002 · AI
INACTIVATION OF CHEMOKINE RECEPTORS BY INTRAKINES$262,500
R01 · FY2001 · AI
A UNIFYING ANTIGEN PRESENTATION STRATEGY$261,625
R01 · FY2001 · AI